Arcturus Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.
Arcturus Therapeutics is a publicly traded company on using the ticker symbol ADHD.
Detailed information on company financials and operating reports can be found here:
: ADHD
Arcturus Therapeutics Annual Revenue and Growth Rate
Note: Arcturus Therapeutics's revenues are gauged from an analysis of company filings.
Investor Activity
Arcturus Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
January 4, 2018
82
100%
$68 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Arcturus Therapeutics is developing and marketing.
Arcturus Therapeutics doesn't have any recent trademark applications, indicating Arcturus Therapeutics is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
STARR Biological compound for medical use, namely, enhanced ribonucleic acid delivered into patient cells; Biological compounds being a component in vaccines; Therapeutic agents for generating protective immune response; Molecularly engineered RNA for increasing expression, and extending duration of expression, of therapeutic proteins upon delivery into patient cells
01/17/2020
ARCTURUS THERAPEUTICS Pharmaceutical preparations, namely, a lipid-enabled drug delivery system for RNA medicines comprising small interfering RNA, messenger RNA, antisense and microRNA oligotherapeutic agents to enable the targeting of any gene in the human genome
03/13/2015
A ARCTURUS THERAPEUTICS Pharmaceutical preparations, namely, a lipid-enabled drug delivery system for RNA medicines comprising small interfering RNA, messenger RNA, antisense and microRNA oligotherapeutic agents to enable the targeting of any gene in the human genome
03/13/2015
See all trademarks and details in the Full Report.
Market Share of Arcturus Therapeutics's Largest Competitors
A competitive analysis shows these companies are in the same general field as Arcturus Therapeutics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Arcturus Therapeutics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Arcturus Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.